TITLE

Dementia Drugs Make the Ticker Sicker

AUTHOR(S)
Wilke, Allan J.
PUB. DATE
November 2009
SOURCE
Internal Medicine Alert;11/15/2009, Vol. 31 Issue 21, p164
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Cholinesterase inhibitors place patients at risk for syncope, bradycardia, permanent pacemaker insertion, and hip fracture.
ACCESSION #
46738305

 

Related Articles

  • Editorial. Krapcho, A. Paul; Atta-ur-Rahman; Talaga, Patrice; Choudhary, M. Iqbal // Mini Reviews in Medicinal Chemistry;Nov2008, Vol. 8 Issue 13, p1311 

    The article discusses various reports published within the issue, including one by Andreas Hilgeroth et al on selective kinase inhibitors as potential anticancer drugs and Georg Petroianu et al on the reactivation of organic phosphorus cholinesterase inhibitors utilizing pyridinium oximes.

  • Contemporary drug treatment. Hines, Silvia E. // Patient Care;2/15/2001, Vol. 35 Issue 3, p54 

    Presents information on cholinesterase inhibitors that can delay the progression of dementia associated with Alzheimer's disease (AD). Trials of cholinesterase inhibitor drugs used; Side effects of the drugs; Prescription processes; Antioxidants and hormones used for AD therapy. INSETS:...

  • inhibitor.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1196 

    A reference entry for "inhibitor" is presented. The term refers to a chemical substance that stops enzyme activity. An alpha-glucosidase inhibitor refers to a drug that lowers blood sugars. An aromatase inhibitors includes drugs that block the synthesis of estrogen. Meanwhile, a cholinesterase...

  • TREATMENT OF DEMENTIA. Overshott, R.; Burns, A. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2005 Supplement, Vol. 76, pv53 

    This article presents information about the treatment of dementia. It is a chronic and progressive clinical syndrome characterized by cognitive impairment. The most common cause of dementia is Alzheimer's disease (AD). Cholinesterase inhibitors (ChEIs) offers the best hope in the treatment of...

  • Should we treat patients with very mild Alzheimer disease with a cholinesterase inhibitor? Gauthier, Serge // Journal of Psychiatry & Neuroscience;Nov2009, Vol. 34 Issue 6, p480 

    A case study of a patient with mild Alzheimer's disease, treated with cholinesterase inhibitor is presented. A 63-year old lawyer, who had consulted a memory clinic and who had a history of Alzheimer in his family, scored a 29/30 in the Mini Mental State Examination and his Montreal Cognitive...

  • Chronic Neuropsychological Sequelae of Cholinesterase Inhibitors in the Absence of Structural Brain Damage: Two Cases of Acute Poisoning. Lola Roldán-Tapia; Leyva, Antonia; Laynez, Francisco; Sánchez Santed, Fernando // Environmental Health Perspectives;Jun2005, Vol. 113 Issue 6, p762 

    Here we describe two cases of carbamate poisoning. Patients AMF and PVM were accidentally poisoned by cholinesterase inhibitors. The medical diagnosis in both cases was overcholinergic syndrome, as demonstrated by exposure to cholinesterase inhibitors. The widespread use of cholinesterase...

  • Donepezil in the Treatment of Vascular Dementia. Ebell, Mark H. // American Family Physician;11/1/2004, Vol. 70 Issue 9, p1681 

    Discusses research being done on cholinesterase inhibitor, donepezil for vascular cognitive impairment. Reference to a study by R. Malouf and J. Birks published in the 2004 issue of "Cochrane Database System Review"; Findings of the study.

  • Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil. Béracochéa, D.; Philippin, J. N.; Meunier, S.; Morain, P.; Bernard, K. // Psychopharmacology;Jul2007, Vol. 193 Issue 1, p63 

    This study compared the effects of S 18986, a positive allosteric modulator of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors, to those of donepezil a cholinesterase inhibitor on memory impairments induced by ageing in a contextual serial discrimination...

  • An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Scholey, Andrew B.; Tildesley, Nicola T. J.; Ballard, Clive G.; Wesnes, Keith A.; Tasker, Andrea; Perry, Elaine K.; Kennedy, David O. // Psychopharmacology;May2008, Vol. 198 Issue 1, p127 

    Species of Salvia (sage) have a long-standing reputation in European medical herbalism, including for memory enhancement. In recent controlled trials, administration of sage extracts with established cholinergic properties improved cognitive function in young adults. This randomised,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics